E. coli and colorectal cancer: a complex relationship that deserves a critical mindset

References

• Abdulamir AS, Hafidh RR, Abu Bakar F. 2011. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 30:11.
   PubMed Web of Science ®Google Scholar
• Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. 2013. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 105:1907–1911.
   PubMed Web of Science ®Google Scholar
• Allen-Vercoe E, Jobin C. 2014. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett. 162:54–61.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Gharaibeh RZ, Mühlbauer M, Perez-Chanona E, Uronis JM, McCafferty J, Fodor AA, Jobin C. 2014. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat Commun. 5:4724.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Jobin C. 2013. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes. 4:253–258.
   PubMedGoogle Scholar
• Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 338:120–123.
   PubMed Web of Science ®Google Scholar
• Balskus EP. 2015. Colibactin: understanding an elusive gut bacterial genotoxin. Nat Prod Rep. 32:1534–1540.
   PubMed Web of Science ®Google Scholar
• Bian X, Fu J, Plaza A, Herrmann J, Pistorius D, Stewart AF, Zhang Y, Müller R. 2013. In vivo evidence for a prodrug activation mechanism during colibactin maturation. Chembiochem. 14:1194–1197.
   PubMed Web of Science ®Google Scholar
• Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. 2014. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 20:859–886.
   PubMed Web of Science ®Google Scholar
• Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrède JP. 2016. Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol. 99:897–908.
   PubMed Web of Science ®Google Scholar
• Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, Ghani ER, Hricak H, Szalay AA, Fong Y, et al. 2008. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res. 14:2295–2302.
   PubMed Web of Science ®Google Scholar
• Brotherton CA, Balskus EP. 2013. A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. J Am Chem Soc. 135:3359–3362.
   PubMed Web of Science ®Google Scholar
• Brotherton CA, Wilson M, Byrd G, Balskus EP. 2015. Isolation of a metabolite from the pks island provides insights into colibactin biosynthesis and activity. Org Lett. 17:1545–1548.
   PubMed Web of Science ®Google Scholar
• Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R. 2013. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 8:e56964.
   PubMed Web of Science ®Google Scholar
• Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. 2011. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol. 37:1–14.
   PubMed Web of Science ®Google Scholar
• Caruso ML, Fucci L. 1990. Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol. 12:601–602.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, et al. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22:299–306.
   PubMed Web of Science ®Google Scholar
• Chaudhuri RR, Henderson IR. 2012. The evolution of the Escherichia coli phylogeny. Infect Genet Evol. 12:214–226.
   PubMed Web of Science ®Google Scholar
• Chen W, Liu F, Ling Z, Tong X, Xiang C. 2012. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 7:e39743.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, et al. 2014. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype . Gut. 63:1932–1942.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Gibold L, Robin F, Dubois D, Pradel N, Darfeuille-Michaud A, Dalmasso G, Delmas J, Bonnet R. 2012. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol. 424:203–214.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 107:11537–11542.
   PubMed Web of Science ®Google Scholar
• Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. 2014. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes. 5:675–680.
   PubMed Web of Science ®Google Scholar
• Danino T, Prindle A, Kwong GA, Skalak M, Li H, Allen K, Hasty J, Bhatia SN. 2015. Programmable probiotics for detection of cancer in urine. Sci Transl Med. 7:289ra84.
   PubMed Web of Science ®Google Scholar
• de Meijere A. 1979. Bonding properties of cyclopropane and their chemical consequences. Angew Chem Int Ed Engl. 18:809–826.
   Web of Science ®Google Scholar
• Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer MA, Nougayrède JP, Oswald E, et al. 2011. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem. 286:35562–35570.
   PubMed Web of Science ®Google Scholar
• Escobar-Páramo P, Grenet K, Le Menac’h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, et al. 2004. Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol.70:5698–5700.
   PubMed Web of Science ®Google Scholar
• Fabbri A, Travaglione S, Ballan G, Loizzo S, Fiorentini CT. 2013. The cytotoxic necrotizing factor 1 from E. coli: a Janus toxin playing with cancer regulators. Toxins. 5:1462–1474.
   PubMed Web of Science ®Google Scholar
• Gagnière J, Bonnin V, Jarrousse AS, Cardamone E, Agus A, Uhrhammer N, Sauvanet P, Déchelotte P, Barnich N, Bonnet R, et al. 2017. Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clin Sci. 131:471–485.
   PubMed Web of Science ®Google Scholar
• Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M. 2016. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 22:501–518.
   PubMed Web of Science ®Google Scholar
• Grasso F, Frisan T. 2015. Bacterial genotoxins: merging the DNA damage response into infection biology. Biomolecules. 5:1762–1782.
   PubMed Web of Science ®Google Scholar
• Healy AR, Nikolayevskiy H, Patel JR, Crawford JM, Herzon SB. 2016. A mechanistic model for colibactin-induced genotoxicity. J Am Chem Soc. 138:15563–15570.
   PubMed Web of Science ®Google Scholar
• Healy AR, Vizcaino MI, Crawford JM, Herzon SB. 2016. Convergent and modular synthesis of candidate precolibactins. Structural revision of precolibactin A. J Am Chem Soc. 138:5426–5432.
   PubMed Web of Science ®Google Scholar
• Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. 2012. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 143:382–389.
   PubMed Web of Science ®Google Scholar
• Hill PJ, Stritzker J, Scadeng M, Geissinger U, Haddad D, Basse-Lüsebrink TC, Gbureck U, Jakob P, Szalay AA. 2011. Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli. PLoS One. 6:e25409.
   PubMed Web of Science ®Google Scholar
• Höckel M, Vaupel P. 2001. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 93:266–276.
   PubMed Web of Science ®Google Scholar
• Homburg S, Oswald E, Hacker J, Dobrindt U. 2007. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 275:255–262.
   PubMed Web of Science ®Google Scholar
• Irving AA, Yoshimi K, Hart ML, Parker T, Clipson L, Ford MR, Kuramoto T, Dove WF, Amos-Landgraf JM. 2014. The utility of Apc-mutant rats in modeling human colon cancer. Dis Model Mech. 7:1215–1225.
   PubMed Web of Science ®Google Scholar
• Joeres-Nguyen-Xuan TH, Boehm SK, Joeres L, Schulze J, Kruis W. 2010. Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. Inflamm Bowel Dis. 16:256–262.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Kuskowski MA, Nougayrède JP, Oswald E. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol. 46:3906–3911.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Oswald E, O’Bryan TT, Kuskowski MA, Spanjaard L. 2002. Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis. 185:774–784.
   PubMed Web of Science ®Google Scholar
• Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 128:891–906.
   PubMed Web of Science ®Google Scholar
• Kipanyula MJ, Seke Etet PF, Vecchio L, Farahna M, Nukenine EN, Nwabo Kamdje AH. 2013. Signaling pathways bridging microbial-triggered inflammation and cancer. Cell Signal. 25:403–416.
   PubMed Web of Science ®Google Scholar
• Kocijancic D, Felgner S, Frahm M, Komoll RM, Iljazovic A, Pawar V, Rohde M, Heise U, Zimmermann K, Gunzer F, et al. 2016. Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential. Oncotarget. 7:22605–22622.
   PubMedGoogle Scholar
• Lara-Tejero M, Galán JE. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science. 290:354–357.
   PubMed Web of Science ®Google Scholar
• Lax AJ. 2005. Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol. 3:343–349.
   PubMed Web of Science ®Google Scholar
• Li ZR, Li J, Gu JP, Lai JYH, Duggan BM, Zhang WP, Li ZL, Li YX, Tong RB, Xu Y, et al. 2016. Divergent biosynthesis yields a cytotoxic aminomalonate-containing precolibactin. Nat Chem Biol. 12:773–775.
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. 2009. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One. 4:e5517.
   PubMed Web of Science ®Google Scholar
• Marchès O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F, Mainil J, Rosenshine I, Sugai M, De Rycke J, et al. 2003. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol. 50:1553–1567.
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. 2004. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology. 127:80–93.
   PubMed Web of Science ®Google Scholar
• Mousa JJ, Newsome RC, Yang Y, Jobin C, Bruner SD. 2017. ClbM is a versatile, cation-promiscuous MATE transporter found in the colibactin biosynthetic gene cluster. Biochem Biophys Res Commun. 482:1233–1239.
   PubMed Web of Science ®Google Scholar
• Mousa JJ, Yang Y, Tomkovich S, Shima A, Newsome RC, Tripathi P, Oswald E, Bruner SD, Jobin C. 2016. MATE transport of the E. coli-derived genotoxin colibactin. Nat Microbiol. 1:15009.
   PubMed Web of Science ®Google Scholar
• Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E, et al. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 313:848–851.
   PubMed Web of Science ®Google Scholar
• Nougayrède JP, Taieb F, De Rycke J, Oswald E. 2005. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13:103–110.
   PubMed Web of Science ®Google Scholar
• Nowrouzian FL, Oswald E. 2012. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb Pathog. 53:180–182.
   PubMed Web of Science ®Google Scholar
• Patwa LG, Fan TJ, Tchaptchet S, Liu Y, Lussier YA, Sartor RB, Hansen JJ. 2011. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology.141:1842–1851.
   PubMed Web of Science ®Google Scholar
• Payros D, Dobrindt U, Martin P, Secher T, Bracarense AP, Boury M, Laffitte J, Pinton P, Oswald E, Oswald IP. 2017. The food contaminant deoxynivalenol exacerbates the genotoxicity of gut microbiota. MBio. 8:e00007–00017.
   Web of Science ®Google Scholar
• Prilassnig M, Wenisch C, Daxboeck F, Feierl G. 2007. Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin Wochenschr. 119:456–462.
   PubMed Web of Science ®Google Scholar
• Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C, et al. 2014. Colonic mucosa-associated diffusely adherent afaC + Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut. 63:761–770.
   PubMed Web of Science ®Google Scholar
• Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, Rabsch W, et al. 2009. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun. 77:4696–4703.
   PubMed Web of Science ®Google Scholar
• Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, et al. 2014. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol. 20:6560–6572.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 14:195–206.
   PubMed Web of Science ®Google Scholar
• Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, Randall TA, Galanko J, Benson A, Sandler RS, et al. 2012. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 6:1858–1868.
   PubMed Web of Science ®Google Scholar
• Sandler RS. 1996. Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am. 25:717–735.
   PubMed Web of Science ®Google Scholar
• Schölzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. 2000. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol. 156:595–605.
   PubMed Web of Science ®Google Scholar
• Secher T, Brehin C, Oswald E. 2016. Early settlers: which E. coli strains do you not want at birth? Am J Physiol Gastrointest Liver Physiol. 311:G123–G129.
   PubMed Web of Science ®Google Scholar
• Secher T, Samba-Louaka A, Oswald E, Nougayrède JP. 2013. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One. 8:e77157.
   PubMed Web of Science ®Google Scholar
• Selander RK, Caugant DA, Ochman H, Mussser JM, Gilmour MN, Whittam TS. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 51:873–884.
   PubMed Web of Science ®Google Scholar
• Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 6:e16393.
   PubMed Web of Science ®Google Scholar
• Stritzker J, Hill PJ, Gentsche I, Szalay AA. 2010. Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice. Bioeng Bugs. 1:139–145.
   PubMedGoogle Scholar
• Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. 2007. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol. 297:151–162.
   PubMed Web of Science ®Google Scholar
• Stritzker J, Weibel S, Seubert C, Götz A, Tresch A, van Rooijen N, Oelschlaeger TA, Hill PJ, Gentschev I, Szalay AA. 2010. Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int J Med Microbiol. 300:449–456.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H. 1998. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology.115:281–286.
   PubMed Web of Science ®Google Scholar
• Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. 2009. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One. 4:e6026.
   PubMed Web of Science ®Google Scholar
• Vizcaino MI, Crawford JM. 2015. The colibactin warhead crosslinks DNA. Nat Chem. 7:411–417.
   PubMed Web of Science ®Google Scholar
• Vizcaino MI, Engel P, Trautman E, Crawford JM. 2014. Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules. J Am Chem Soc. 136:9244–9247.
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. 2012. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6:320–329.
   PubMed Web of Science ®Google Scholar
• Zha L, Wilson MR, Brotherton CA, Balskus EP. 2016. Characterization of polyketide synthase machinery from the pks island facilitates isolation of a candidate precolibactin. ACS Chem Biol. 11:1287–1295.
   PubMed Web of Science ®Google Scholar